As a potential therapeutic molecule, deguelin can inhibit angiogenesis and tumor metastasis through a variety of targets, such as MMPs, HIF-1α, FAK and PI3K/Akt pathway (Nguyen et al., 2015). The gene discussed is AKT1; the disease is neoplasm.